Fortress Biotech (FBIO) Non-Current Assets (2010 - 2026)

Fortress Biotech's Non-Current Assets history runs 15 years deep, the most recent figure standing at $61.7 million for Q4 2025.

• In Q4 2025, Non-Current Assets rose 14.59% year-over-year to $61.7 million; the TTM figure through Dec 2025 stood at $225.3 million (up 21.77% YoY), while the FY2025 annual figure was $61.7 million, up 14.59% from the prior year.
• Non-Current Assets for Q4 2025 stood at $61.7 million, down from $62.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $106.6 million in Q3 2021, with the low at -$314.6 million in Q2 2021.
• The 5-year median for Non-Current Assets is $53.5 million (2023), against an average of $40.2 million.
• The sharpest annual moves came in 2021 and 2022: Non-Current Assets plunged 557.51% in 2021, then surged 120.65% in 2022.
• Fortress Biotech's Non-Current Assets stood at $50.0 million in 2021, then climbed by 27.63% to $63.9 million in 2022, then dropped by 20.93% to $50.5 million in 2023, then advanced by 6.63% to $53.9 million in 2024, then grew by 14.59% to $61.7 million in 2025.
• Business Quant data shows FBIO's Non-Current Assets at $61.7 million in Q4 2025, $62.9 million in Q3 2025, and $49.5 million in Q2 2025.